Safeguard Patients on Anticoagulants During Care Transitions
December 2021
You play a key role in ensuring safe use of anticoagulants during transitions of care.
Admission. Document doses and durations carefully.
Also confirm the indication, such as rivaroxaban 2.5 mg BID for peripheral artery disease... 10 mg daily for VTE prophylaxis...or 20 mg daily to prevent a stroke from atrial fibrillation or to treat a VTE.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote